Bicalutamide-d4
Bicalutamide-d4 is the deuterium labeled Bicalutamide. Bicalutamide is an orally active non-steroidal androgen receptor (AR) antagonist. Bicalutamide can be used for the research of prostate cancer.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1185035-71-5
- Fòrmula: C18H10D4F4N2O4S
- Peso molecular:434.40
-
Almacenamiento:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Protocolo
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
HY-N0475
TriptophenolideAndrogen Receptor Antagonist -
HY-14248S
Letrozole-d4Stable Isotope -
HY-70002S
DeutenzalutamideAndrogen Receptor Antagonist -
HY-B1986
p,p'-DDEAndrogen Receptor Antagonist -
HY-N0437S
Progesterone-d9Stable Isotope -
HY-N7045
Isosilybin BNatural Product -
HY-109619
D4-abirateroneAbiraterone Metabolite -
HY-N0475R
Triptophenolide (Standard)Androgen Receptor Antagonist -
HY-B0412S
Estriol-d2Stable Isotope -
HY-B0234S1
Estrone-d2Stable Isotope -
HY-122025
AC-262536Androgen Receptor Agonist -
HY-113405S1
21-Deoxycortisol-d8Stable Isotope
Actividad biológica
Descripciòn
In Vitro
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Aplicación
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
No. CAS 1185035-71-5
-
Unlabeled CAS 90357-06-5
-
Appearance Solid
-
Peso molecular 434.40
-
Fòrmula C18H10D4F4N2O4S
-
Color White to off-white
-
SMILES
O=C(NC1=CC=C(C#N)C(C(F)(F)F)=C1)C(C)(O)CS(=O)(C2=C([2H])C([2H])=C(F)C([2H])=C2[2H])=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Protocolo
-
Research Protocol for Endocrine Diseases
Endocrine diseases often arise from disrupted hormone production, hormone signaling, or target-tissue responsiveness; for diabetes-focused endocrine disease models, insulin signaling regulates glucose uptake, hepatic glucose output, lipid metabolism, and β-cell compensation. Type 2 diabetes develops through interacting defects in insulin resistance, β-cell dysfunction, adipose inflammation, hepatic glucose overproduction, altered incretin signaling, and ectopic lipid metabolism. A major unresolved question is whether endocrine dysfunction is driven primarily by target-tissue insulin resistance, intrinsic β-cell failure, immune/inflammatory stress, or combined multi-organ failure that differs by disease stage.
Pureza y Documentación
-
Ficha de datos (269 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Bicalutamide-d4 Related Classifications
HY-14249S Related Classifications
Powered by Bioz